Medtronic plc Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net
Medtronic plc (MDT) reported Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net of $92.00 million for the 12-month period ending 2017-04-28, per its 10-K filed 2019-06-21.
Discontinued › Notes › Compensation Related Costs
us-gaap:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet · last filed 2019-06-21
- Medtronic plc adjustment to additional paid in capital, income tax effect from share-based compensation, net for the quarter ending 2017-04-28 was $12.00M.
- Medtronic plc adjustment to additional paid in capital, income tax effect from share-based compensation, net for the quarter ending 2017-01-27 was $5.00M.
- Medtronic plc adjustment to additional paid in capital, income tax effect from share-based compensation, net for the quarter ending 2016-10-28 was $18.00M.
- Medtronic plc adjustment to additional paid in capital, income tax effect from share-based compensation, net for the quarter ending 2016-07-29 was $57.00M.
- Medtronic plc adjustment to additional paid in capital, income tax effect from share-based compensation, net for fiscal 2017 was $92.00M, a 12.20% increase from fiscal 2016.
- Medtronic plc adjustment to additional paid in capital, income tax effect from share-based compensation, net for fiscal 2016 was $82.00M, a 1.23% increase from fiscal 2015.
- Medtronic plc adjustment to additional paid in capital, income tax effect from share-based compensation, net for fiscal 2015 was $81.00M, a 179.31% increase from fiscal 2014.
- Medtronic plc adjustment to additional paid in capital, income tax effect from share-based compensation, net for fiscal 2014 was $29.00M.
| Period end | Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net 3 month | Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net 6 month | Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net 9 month | Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net 12 month |
|---|---|---|---|---|
| 2017-04-28 | $12.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-06-21 | $17.00M derived: sum of 2 quarters · filed 2019-06-21 | $35.00M derived: sum of 3 quarters · filed 2019-06-21 | $92.00M 10-K · filed 2019-06-21 |
| 2017-01-27 | $5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-02 | $23.00M derived: sum of 2 quarters · filed 2018-03-02 | $80.00M 10-Q · filed 2018-03-02 | |
| 2016-10-28 | $18.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-12-04 | $75.00M 10-Q · filed 2017-12-04 | ||
| 2016-07-29 | $57.00M 10-Q · filed 2016-09-07 | |||
| 2016-04-29 | $82.00M 10-K · filed 2018-06-22 | |||
| 2015-04-24 | $81.00M 10-K · filed 2017-06-27 | |||
| 2014-04-25 | $29.00M 10-K · filed 2016-06-28 | |||
| 2013-04-26 | -$7.00M 10-K · filed 2015-06-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B |